603392.SS
603392.SS
CNE100004090
BEIJING WANTAI BIOLOGICAL PHARM
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.818.967.458 2.245.403.246
19.0%
Cost of Revenue 921.826.886 759.044.722
21.4%
Gross Profit 897.140.572 1.486.358.523
39.6%
1.323.545.970 1.484.058.046
10.8%
Operating Income -426.405.398 2.300.477
18635.5%
Pretax Income -480.885.756 67.480.833
812.6%
Net Income Common Stockholders -398.267.667 106.235.426
474.9%
-- --
--
-- --
--
ende